W ASHINGTON — In a far-ranging, free-wheeling 90-minute acceptance speech for the Republican nomination to the presidency, ...
Learn the signs and symptoms that may warrant a cognitive assessment for conditions like Alzheimer's and dementia.
Medicare (and Medicare Advantage) provide some coverage for dementia, beginning with the diagnosis, says Baumgart.
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.
Alzheimer’s has no cure and can’t be reversed, but the FDA-approved drug can slow cognitive decline. Eli Lilly reported that ...
FDA designation enables expedited clinical development and regulatory review timelines for Lomecel-B™ – – Second designation received for Lomecel-B™ for the treatment of mild Alzheimer’s Disease after ...
Longeveron Inc. (LGVN) said Wednesday that the U.S. Food and Drug Administration has granted Fast Track designation to Lomecel-B for ...
Rick Barry appointed Executive Chairman of the BoardRemi Barbier resigns as President and CEO and from the Board of DirectorsCassava initiates ...
LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) announced that its primary treatment, Lomecel-B, has been granted Fast Track designation by the FDA only a week after being granted ...
It's not a cure-- but it is a step in the right direction.This month-- a new medication for alzheimer's, called 'kinsul'a, ...
Positrigo, a Swiss based company developing nuclear medical imaging devices to advance functional brain imaging, has achieved ...